Attached files

file filename
EX-32.2 - EX-32.2 - ABBOTT LABORATORIESa2230875zex-32_2.htm
EX-32.1 - EX-32.1 - ABBOTT LABORATORIESa2230875zex-32_1.htm
EX-31.2 - EX-31.2 - ABBOTT LABORATORIESa2230875zex-31_2.htm
EX-31.1 - EX-31.1 - ABBOTT LABORATORIESa2230875zex-31_1.htm
EX-23.1 - EX-23.1 - ABBOTT LABORATORIESa2230875zex-23_1.htm
EX-21 - EX-21 - ABBOTT LABORATORIESa2230875zex-21.htm
EX-12 - EX-12 - ABBOTT LABORATORIESa2230875zex-12.htm
EX-10.62 - EX-10.62 - ABBOTT LABORATORIESa2230875zex-10_62.htm
EX-10.61 - EX-10.61 - ABBOTT LABORATORIESa2230875zex-10_61.htm
EX-10.60 - EX-10.60 - ABBOTT LABORATORIESa2230875zex-10_60.htm
EX-10.59 - EX-10.59 - ABBOTT LABORATORIESa2230875zex-10_59.htm
EX-10.10 - EX-10.10 - ABBOTT LABORATORIESa2230875zex-10_10.htm
EX-4.22 - EX-4.22 - ABBOTT LABORATORIESa2230875zex-4_22.htm
10-K - 10-K - ABBOTT LABORATORIESa2230875z10-k.htm

Exhibit 10.49

 

[Date]

 

To:                             [Executive]

 

Re:                             Change in Control (CIC) Agreement- Notification of Extension

 

Abbott’s Board of Directors recently extended your Change in Control (CIC) agreement. The CIC agreement provides you with financial, health and welfare benefits in the event of a Change in Control.  No action is required on your part to continue participation in the CIC agreement.

 

You are hereby notified that your current Change in Control Agreement, which was set to expire on December 31, 2016, has been extended to December 31, 2018.

 

Please retain a copy of this Notification of Extension with your important records.